Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

1,1,1-trifluoro-2-(4-(1H-pyrazol-1-yl)phenyl)-3-(4-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol MeSH Supplementary Concept Data 2025


MeSH Supplementary
1,1,1-trifluoro-2-(4-(1H-pyrazol-1-yl)phenyl)-3-(4-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol
Unique ID
C556243
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C556243
Entry Term(s)
MK 5046
MK-5046
MK5046
Registry Numbers
0
Heading Mapped to
*Imidazoles
*Pyrazoles
Frequency
6
Note
an anti-obesity agent and bombesin receptor subtype-3 agonist
Source
J Pharmacol Exp Ther 2011 Feb;336(2):356-64
Indexing Information
Receptors, Bombesin
Date of Entry
2011/03/02
Revision Date
2011/03/02
1,1,1-trifluoro-2-(4-(1H-pyrazol-1-yl)phenyl)-3-(4-((1-(trifluoromethyl)cyclopropyl)methyl)-1H-imidazol-2-yl)propan-2-ol Preferred
MK 5046 Narrower
page delivered in 0.002s